|
Oncogenes
|
| 25 |
ABL1 |
v-abl Abelson murine leukemia viral oncogene homolog 1 |
1 |
| 3726 |
JUNB |
jun B proto-oncogene |
2 |
| 7409 |
VAV1 |
vav 1 oncogene |
1 |
| 6757 |
SSX2 |
synovial sarcoma, X breakpoint 2 |
3 |
| 2130 |
EWSR1 |
Ewing sarcoma breakpoint region 1 |
3 |
| 2241 |
FER |
fer (fps/fes related) tyrosine kinase (phosphoprotein NCP94) |
2 |
| 369 |
ARAF |
v-raf murine sarcoma 3611 viral oncogene homolog |
1 |
| 4613 |
MYCN |
v-myc myelocytomatosis viral related oncogene |
2 |
| 2534 |
FYN |
FYN oncogene related to SRC, FGR, YES |
2 |
| 727735 |
unassigned |
similar to TBC1 domain family member 3 |
1 |
| 51513 |
ETV7 |
ets variant gene 7 (TEL2 oncogene) |
2 |
| 5894 |
RAF1 |
v-raf-1 murine leukemia viral oncogene homolog 1 |
2 |
| 4193 |
MDM2 |
Mdm2, transformed 3T3 cell double minute 2, p53 binding protein |
1 |
| 4609 |
MYC |
v-myc myelocytomatosis viral oncogene homolog |
1 |
| 2353 |
FOS |
v-fos FBJ murine osteosarcoma viral oncogene homolog |
3 |
| 7410 |
VAV2 |
vav 2 oncogene |
1 |
| 4194 |
MDM4 |
Mdm4, transformed 3T3 cell double minute 4, p53 binding protein |
1 |
| 2118 |
ETV4 |
ets variant gene 4 (E1A enhancer binding protein, E1AF) |
3 |
| 598 |
BCL2L1 |
BCL2-like 1 |
3 |
| 55885 |
LMO3 |
LIM domain only 3 (rhombotin-like 2) |
1 |
| 3265 |
HRAS |
v-Ha-ras Harvey rat sarcoma viral oncogene homolog |
2 |
| 4893 |
NRAS |
neuroblastoma RAS viral (v-ras) oncogene homolog |
1 |
|
|
Total
|
39
|
|
Tumor suppressors
|
| 5934 |
RBL2 |
retinoblastoma-like 2 (p130) |
1 |
| 3482 |
IGF2R |
insulin-like growth factor 2 receptor |
1 |
| 5925 |
RB1 |
retinoblastoma 1 (including osteosarcoma) |
1 |
| 54984 |
unassigned |
PIN2-interacting protein 1 |
1 |
| 4017 |
LOXL2 |
lysyl oxidase-like 2 |
3 |
| 29997 |
GLTSCR2 |
glioma tumor suppressor candidate region gene 2 |
3 |
| 2014 |
EMP3 |
epithelial membrane protein 3 |
1 |
| 672 |
BRCA1 |
breast cancer 1, early onset |
2 |
| 54879 |
ST7L |
suppression of cancerigenicity 7 like |
2 |
| 51147 |
ING4 |
inhibitor of growth family, member 4 |
1 |
| 7982 |
ST7 |
suppression of cancerigenicity 7 |
1 |
| 51566 |
ARMCX3 |
armadillo repeat containing, X-linked 3 |
4 |
| 84695 |
LOXL3 |
lysyl oxidase-like 3 |
2 |
| 79961 |
DENND2D |
DENN/MADD domain containing 2D |
2 |
| 7157 |
TP53 |
cancer protein p53 (Li-Fraumeni syndrome) |
1 |
| 7248 |
TSC1 |
tuberous sclerosis 1 |
1 |
| 54768 |
HYDIN |
hydrocephalus inducing homolog |
3 |
| 581 |
BAX |
BCL2-associated X protein |
1 |
| 1026 |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
5 |
| 1029 |
CDKN2A |
cyclin-dependent kinase inhibitor 2A |
1 |
| 10263 |
CDK2AP2 |
CDK2-associated protein 2 |
1 |
|
|
Total
|
38
|
